PT - JOURNAL ARTICLE AU - Anne L. Wyllie AU - John Fournier AU - Arnau Casanovas-Massana AU - Melissa Campbell AU - Maria Tokuyama AU - Pavithra Vijayakumar AU - Bertie Geng AU - M. Catherine Muenker AU - Adam J. Moore AU - Chantal B.F. Vogels AU - Mary E. Petrone AU - Isabel M. Ott AU - Peiwen Lu AU - Arvind Venkataraman AU - Alice Lu-Culligan AU - Jonathan Klein AU - Rebecca Earnest AU - Michael Simonov AU - Rupak Datta AU - Ryan Handoko AU - Nida Naushad AU - Lorenzo R. Sewanan AU - Jordan Valdez AU - Elizabeth B. White AU - Sarah Lapidus AU - Chaney C. Kalinich AU - Xiaodong Jiang AU - Daniel J. Kim AU - Eriko Kudo AU - Melissa Linehan AU - Tianyang Mao AU - Miyu Moriyama AU - Ji Eun Oh AU - Annsea Park AU - Julio Silva AU - Eric Song AU - Takehiro Takahashi AU - Manabu Taura AU - Orr-El Weizman AU - Patrick Wong AU - Yexin Yang AU - Santos Bermejo AU - Camila Odio AU - Saad B. Omer AU - Charles S. Dela Cruz AU - Shelli Farhadian AU - Richard A. Martinello AU - Akiko Iwasaki AU - Nathan D. Grubaugh AU - Albert I. Ko TI - Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs AID - 10.1101/2020.04.16.20067835 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.16.20067835 4099 - http://medrxiv.org/content/early/2020/04/22/2020.04.16.20067835.short 4100 - http://medrxiv.org/content/early/2020/04/22/2020.04.16.20067835.full AB - Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR detection of SARS-CoV-2 from nasopharyngeal swabs. Low sensitivity, exposure risks to healthcare workers, and global shortages of swabs and personal protective equipment, however, necessitate the validation of new diagnostic approaches. Saliva is a promising candidate for SARS-CoV-2 diagnostics because (1) collection is minimally invasive and can reliably be self-administered and (2) saliva has exhibited comparable sensitivity to nasopharyngeal swabs in detection of other respiratory pathogens, including endemic human coronaviruses, in previous studies. To validate the use of saliva for SARS-CoV-2 detection, we tested nasopharyngeal and saliva samples from confirmed COVID-19 patients and self-collected samples from healthcare workers on COVID-19 wards. When we compared SARS-CoV-2 detection from patient-matched nasopharyngeal and saliva samples, we found that saliva yielded greater detection sensitivity and consistency throughout the course of infection. Furthermore, we report less variability in self-sample collection of saliva. Taken together, our findings demonstrate that saliva is a viable and more sensitive alternative to nasopharyngeal swabs and could enable at-home self-administered sample collection for accurate large-scale SARS-CoV-2 testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding sources had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding authors had full access to all data in the study and had final responsibility for the decision to submit for publication.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated and/or analysed during the current study are available from the corresponding author on reasonable request.